About Anji Pharmaceuticals

Anji Pharmaceuticals focuses on developing therapeutics targeting high-value genetic markers identified through human genetic validation. The company aims to address unmet medical needs by leveraging genetic insights to create more effective treatments for complex diseases.

```xml <problem> Many complex diseases lack effective treatments due to incomplete understanding of the underlying genetic factors that contribute to disease development and progression. Traditional drug development approaches often overlook the potential of targeting specific genetic markers that are highly relevant to disease pathology. This can lead to lower success rates in clinical trials and limited therapeutic options for patients. </problem> <solution> Anji Pharmaceuticals develops targeted therapeutics based on human genetic validation, focusing on high-value genetic markers to address unmet medical needs in complex diseases. By leveraging insights from human genetics, the company aims to create more effective and personalized treatments. Their approach involves identifying specific genes or genetic variations that play a crucial role in disease pathways and then designing therapies that directly target these genetic factors. This precision medicine strategy seeks to improve treatment outcomes and reduce the risk of adverse effects by tailoring interventions to the individual's genetic profile. </solution> <features> - Focus on therapeutics development - Target identification through human genetic validation - Development of treatments for complex diseases - Personalized medicine approach based on genetic markers </features> <target_audience> The primary target audience includes patients with complex diseases who may benefit from genetically targeted therapies, as well as pharmaceutical companies seeking to expand their pipelines with innovative, genetically validated drug candidates. </target_audience> ```

What does Anji Pharmaceuticals do?

Where is Anji Pharmaceuticals located?

Anji Pharmaceuticals is based in Cambridge, United Kingdom.

When was Anji Pharmaceuticals founded?

Anji Pharmaceuticals was founded in 2018.

How much funding has Anji Pharmaceuticals raised?

Anji Pharmaceuticals has raised 105000000.

Location

Cambridge, United Kingdom

Founded

2018

Funding

105000000

Employees

3 employees

Major Investors

Xiamen Changrong Investment Management

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Anji Pharmaceuticals

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

anjipharma.com 700+

Crunchbase

Founded 2018 – Cambridge, United Kingdom

Funding

Estimated Funding

$100M+

Major Investors

Xiamen Changrong Investment Management

Team (<5)

No team information available.

Company Description

Problem

Many complex diseases lack effective treatments due to incomplete understanding of the underlying genetic factors that contribute to disease development and progression. Traditional drug development approaches often overlook the potential of targeting specific genetic markers that are highly relevant to disease pathology. This can lead to lower success rates in clinical trials and limited therapeutic options for patients.

Solution

Anji Pharmaceuticals develops targeted therapeutics based on human genetic validation, focusing on high-value genetic markers to address unmet medical needs in complex diseases. By leveraging insights from human genetics, the company aims to create more effective and personalized treatments. Their approach involves identifying specific genes or genetic variations that play a crucial role in disease pathways and then designing therapies that directly target these genetic factors. This precision medicine strategy seeks to improve treatment outcomes and reduce the risk of adverse effects by tailoring interventions to the individual's genetic profile.

Features

Focus on therapeutics development

Target identification through human genetic validation

Development of treatments for complex diseases

Personalized medicine approach based on genetic markers

Target Audience

The primary target audience includes patients with complex diseases who may benefit from genetically targeted therapies, as well as pharmaceutical companies seeking to expand their pipelines with innovative, genetically validated drug candidates.